Lianyungang, China

Xuebing Zhu



Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Xuebing Zhu in Dry Powder Inhaler Technology

Introduction

Xuebing Zhu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of dry powder inhalers. With a total of 3 patents to his name, Zhu's work focuses on enhancing the efficiency and usability of inhalation devices.

Latest Patents

One of Zhu's latest patents is a novel dry powder inhaler. This innovative device features a plurality of capsule chambers arranged in parallel, allowing for the separate dispensing of active components from a composite product or their mixture. The design of the dry powder inhaler is characterized by its simple structure and ease of operation. Furthermore, the parameters of the air inlet channels and the air outlet channel can be adjusted through each capsule chamber, depending on the properties of the powder. This adaptability ensures an appropriate particle distribution for each active component, enhancing the effectiveness of the inhaler.

Career Highlights

Xuebing Zhu is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts in inhalation technology. His work has garnered attention for its potential to improve patient outcomes in respiratory therapies.

Collaborations

Zhu collaborates with several talented individuals in his field, including Changhui Li and Liping Zhou. Their combined expertise contributes to the innovative projects at Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conclusion

Xuebing Zhu's contributions to the development of dry powder inhalers represent a significant advancement in pharmaceutical technology. His innovative designs and collaborative efforts continue to shape the future of respiratory treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…